Regular readers will be aware that we have been speaking passive immunity for COVID19 for over a year since the USA approved Regeneron’s cocktail for high risk patients with COVID19, particularly if you have no ability to make you own antibodies. Our friends over at CLL Society report that the FDA have now extended this … Continue reading USA blood cancer patients – Monoclonal antibodies now available if you have you been exposed to COVID19 or are you at high risk of exposure. When will the UK catch up?